Understanding the role of the gut microbiome in brain development and its association with neurodevelopmental psychiatric disorders

S Dash, YA Syed, MR Khan - Frontiers in Cell and Developmental …, 2022 - frontiersin.org
The gut microbiome has a tremendous influence on human physiology, including the
nervous system. During fetal development, the initial colonization of the microbiome …

C-reactive protein levels in schizophrenia: a review and meta-analysis

BJ Miller, N Culpepper… - Clinical schizophrenia & …, 2014 - meridian.allenpress.com
There is an impression in the literature that schizophrenia is associated with increased
inflammation, including abnormal blood levels of the acute phase reactant C-reactive protein …

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

BS Fernandes, J Steiner, HG Bernstein, S Dodd… - Molecular …, 2016 - nature.com
The inflammatory hypothesis of schizophrenia (SZ) posits that inflammatory processes and
neural–immune interactions are involved in its pathogenesis, and may underpin some of its …

Towards an immunophenotype of schizophrenia: progress, potential mechanisms, and future directions

BJ Miller, DR Goldsmith - Neuropsychopharmacology, 2017 - nature.com
The evidence to date, coupled with advances in immunology and genetics has afforded the
field an unparalleled opportunity to investigate the hypothesis that a subset of patients with …

Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries

J Davis, S Moylan, BH Harvey… - Australian & New …, 2014 - journals.sagepub.com
Objective: Whilst dopaminergic dysfunction remains a necessary component involved in the
pathogenesis of schizophrenia, our current pharmacological armoury of dopamine …

[HTML][HTML] Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome

W Beumer, RC Drexhage, H De Wit, MA Versnel… - …, 2012 - Elsevier
At present there are strong indications of a shared vulnerability factor for schizophrenia (SZ),
diabetes and the metabolic syndrome (metS). In this study we focus on an aberrantly …

Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis

V Lestra, B Romeo, C Martelli, A Benyamina… - Schizophrenia …, 2022 - Elsevier
Background Patients with schizophrenia display peripheral inflammation but the impact of
illness phase is not clear. Our meta-analysis investigated the difference in CRP levels …

A systematic review of clozapine‐associated inflammation and related monitoring

JG Leung, L Zhang, M Markota… - … : The Journal of …, 2023 - Wiley Online Library
Clozapine is an effective antipsychotic medication used for treatment‐resistant
schizophrenia. However, it is underutilized due to rigorous hematologic monitoring …

COVID-19 in people with schizophrenia: potential mechanisms linking schizophrenia to poor prognosis

M Mohan, BI Perry, P Saravanan, SP Singh - Frontiers in Psychiatry, 2021 - frontiersin.org
As the global burden of mortality from COVID-19 continues to rise, an understanding of who
is most at risk of adverse outcomes is of paramount importance. Pre-existing …

[HTML][HTML] Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology

BJ Miller, DR Goldsmith - Biomarkers in Neuropsychiatry, 2019 - Elsevier
The longstanding investigation of immune system abnormalities, including inflammation, in
schizophrenia has tremendous renewed interest as an area of research. Presently, the field …